Status:
UNKNOWN
Safety of External Electrocardioversion in Device Patients
Lead Sponsor:
Universitätsklinikum Köln
Conditions:
Atrial Arrhythmia
Eligibility:
All Genders
18-99 years
Brief Summary
Arrhythmias of the atria of the heart are a common comorbidity in patients with cardiac rhythm management devices, such as pacemakers and implantable cardioverter/defibrillators (ICD). External electr...
Detailed Description
Introduction Atrial arrhythmias are a common comorbidity in patients with cardiac rhythm management (CRM) devices, such as pacemakers and ICD. External electrical cardioversion is an established metho...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Informed, written consent
- Atrial or ventricular arrhythmia with indication for CV
- Status post CRM implantation, including CRT-D
Exclusion
- Age \< 18 years
- Patients under guardianship or with mental disorders / disabilities
- lead implantation \< 4 weeks prior to CV
- contraindications for eCV or transoesophageal echocardiographie (TOE)
Key Trial Info
Start Date :
September 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2018
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT02245009
Start Date
September 1 2014
End Date
December 1 2018
Last Update
November 6 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Cologne
Cologne, Germany, 50937